We are live on
!
Find out more
Vanguard Portfolio Management Portfolio holdings
AUM
$2.22T
This Fund
S&P 500
This Quarter
Est. Return
+25.71%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.22T
AUM Growth
+$305B
(+16%)
Cap. Flow
+$19.5B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
21.57%
Holding
3,286
New
192
Increased
2,077
Reduced
864
Closed
145
Avg Time Held
0.9
quarters
Top 10 Avg Time Held
0.8
quarters
Top 20 Avg Time Held
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$1.74B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$1.66B |
| 3 |
NVIDIA
NVDA
|
+$1.58B |
| 4 |
Micron Technology
MU
|
+$1.23B |
| 5 |
Devon Energy
DVN
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$2.45B |
| 2 |
Seagate
STX
|
+$2.36B |
| 3 |
Western Digital
WDC
|
+$1.98B |
| 4 |
Honeywell
HON
|
+$1.74B |
| 5 |
Corning
GLW
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Financials | 11.67% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 9.73% |
| 5 | Consumer Discretionary | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2001
Metallus
MTUS
$829M
| $19.9M | ﹤0.01% |
1,066,248
-7,898
| -0.7% | -$148K |
2026 Q1
1 quarter
|
|
2002
Tejon Ranch
TRC
$442M
| $19.9M | ﹤0.01% |
1,062,986
+42,813
| +4% | +$828K |
2026 Q1
1 quarter
|
|
2003
Rocket Pharmaceuticals
RCKT
$281M
| $19.9M | ﹤0.01% |
5,810,033
+1,119,818
| +24% | +$3.72M |
2026 Q1
1 quarter
|
|
2004
NWPX Infrastructure Inc
NWPX
$976M
| $19.8M | ﹤0.01% |
132,243
+56,805
| +75% | +$6.22M |
2026 Q1
1 quarter
|
|
|
PVLA
2005
Palvella Therapeutics
PVLA
$2B
| $19.7M | ﹤0.01% |
128,962
+38,104
| +42% | +$4.62M |
2026 Q1
1 quarter
|
|
2006
Hagerty
HGTY
$1.58B
| $19.7M | ﹤0.01% |
1,650,329
+19,358
| +1% | +$207K |
2026 Q1
1 quarter
|
|
2007
Itaú Unibanco
ITUB
$112B
| $19.5M | ﹤0.01% |
2,391,522
-297,782
| -11% | -$2.47M |
2026 Q1
1 quarter
|
|
2008
Ocular Therapeutix
OCUL
$1.66B
| $19.4M | ﹤0.01% |
1,973,130
+378,464
| +24% | +$3.43M |
2026 Q1
1 quarter
|
|
2009
Eos Energy Enterprises
EOSE
$918M
| $19.3M | ﹤0.01% |
3,289,703
+446,895
| +16% | +$3.11M |
2026 Q1
1 quarter
|
|
2010
QuinStreet
QNST
$900M
| $19.2M | ﹤0.01% |
1,310,488
-22,854
| -2% | -$287K |
2026 Q1
1 quarter
|
|
2011
Monte Rosa Therapeutics
GLUE
$879M
| $19.2M | ﹤0.01% |
791,932
+275,966
| +53% | +$5.21M |
2026 Q1
1 quarter
|
|
|
MBX
2012
MBX Biosciences
MBX
$2.56B
| $19.1M | ﹤0.01% |
346,717
+53,422
| +18% | +$1.87M |
2026 Q1
1 quarter
|
|
2013
Old Second Bancorp
OSBC
$1.25B
| $19.1M | ﹤0.01% |
819,368
+106,935
| +15% | +$2.29M |
2026 Q1
1 quarter
|
|
2014
Amylyx Pharmaceuticals
AMLX
$3.53B
| $19.1M | ﹤0.01% |
1,061,534
+116,753
| +12% | +$1.81M |
2026 Q1
1 quarter
|
|
|
PPTA
2015
Perpetua Resources
PPTA
$2.58B
| $18.9M | ﹤0.01% |
911,364
+82,447
| +10% | +$2.24M |
2026 Q1
1 quarter
|
|
2016
NextDecade
NEXT
$1.76B
| $18.7M | ﹤0.01% |
2,483,302
+40,727
| +2% | +$322K |
2026 Q1
1 quarter
|
|
2017
Cerence
CRNC
$381M
| $18.7M | ﹤0.01% |
1,648,666
+215,512
| +15% | +$2.11M |
2026 Q1
1 quarter
|
|
2018
Savers
SVV
$1.41B
| $18.7M | ﹤0.01% |
1,848,535
+11,332
| +0.6% | +$98.3K |
2026 Q1
1 quarter
|
|
2019
Kodak
KODK
$902M
| $18.6M | ﹤0.01% |
2,012,595
+329,764
| +20% | +$3.62M |
2026 Q1
1 quarter
|
|
2020
Stoke Therapeutics
STOK
$1.6B
| $18.6M | ﹤0.01% |
566,993
+104,311
| +23% | +$3.35M |
2026 Q1
1 quarter
|
|
2021
Liberty Global Class A
LBTYA
$2.95B
| $18.5M | ﹤0.01% |
1,631,352
-292,804
| -15% | -$3.5M |
2026 Q1
1 quarter
|
|
2022
MarineMax
HZO
$1.16B
| $18.4M | ﹤0.01% |
503,144
+26,452
| +6% | +$850K |
2026 Q1
1 quarter
|
|
|
MANE
2023
Veradermics Inc
MANE
$5.47B
| $18.3M | ﹤0.01% |
149,054
+144,517
| +3,185% | +$13.5M |
2026 Q1
1 quarter
|
|
2024
FuelCell Energy
FCEL
$1.44B
| $18.2M | ﹤0.01% |
505,082
+449,040
| +801% | +$7.29M |
2026 Q1
1 quarter
|
|
2025
Amalgamated Financial
AMAL
$1.39B
| $18.2M | ﹤0.01% |
396,083
-47,895
| -11% | -$2.02M |
2026 Q1
1 quarter
|
|
Similar funds
Vanguard Portfolio Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Portfolio Management held 3,286 positions worth $2.22T, up 16% from $1.91T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Vanguard Portfolio Management's Q2 2026 filing shows 192 new, 2,077 increased, 864 reduced and 145 closed positions. Its largest new stake was SpaceX: 10,225,389 shares worth $1.75B. The largest sale was Marvell Technology, an estimated $2.45B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.
- Vanguard Portfolio Management's largest Q2 2026 buy was SpaceX: 10,225,389 shares worth $1.75B.
- Vanguard Portfolio Management added most to NVIDIA in Q2 2026, an estimated $1.58B increase.
- Vanguard Portfolio Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $2.45B.
- Vanguard Portfolio Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.3B.
- Vanguard Portfolio Management's ten largest holdings make up 22% of its $2.22T portfolio in Q2 2026.
- Vanguard Portfolio Management opened 192 new positions and closed 145 in Q2 2026.
- Vanguard Portfolio Management's portfolio value rose 16% quarter-over-quarter to $2.22T.
Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.